Human THP-1 monocytic leukemic cells induced to undergo monocytic differentiation by bryostatin 1 are refractory to proteasome inhibitor-induced apoptosis

Cancer Research

Volumn 60, Issue 16, 2000, Pages 4377-4385

  Chen, C ^a   Lin, H ^a   Karanes, C ^a   Pettit, G R ^a   Chen, B D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRYOSTATIN 1; CASPASE 3; CASPASE 9; CYTOCHROME C; PROTEASOME INHIBITOR; PROTEIN KINASE C ACTIVATOR; UBIQUITIN;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MEDIATOR RELEASE; MEMBRANE MARKER; MITOSIS INHIBITION; MONOCYTIC LEUKEMIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TUMOR CELL CULTURE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASE 9; CASPASES; CELL DIFFERENTIATION; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; CYTOCHROME C GROUP; ENZYME ACTIVATION; HUMANS; LACTONES; LEUKEMIA, MONOCYTIC, ACUTE; LEUKEMIA, PROMYELOCYTIC, ACUTE; LEUPEPTINS; MACROLIDES; MITOCHONDRIA; MONOCYTES; MULTIENZYME COMPLEXES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-BCL-2; UBIQUITINS;

EID: 0034662643     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. New insights into the mechanisms and importance of the proteasome in intracellular protein degradation
2. Activation of cyclin E/Cdk2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E
3. Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation
4. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
5. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB
6. Mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway
7. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
8. In vivo ubiquitination and proteasomemediated degradation of p53
9. Differential regulation of c-Jun and JunD by ubiquitin-dependent protein degradation
10. Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: Identification and characterization of the conjugating enzymes
11. Cell cycle regulation by the ubiquitin pathway
12. The ubiquitin-proteasome pathway in cancer
13. Apoptosis induction resulting from proteasome inhibition
14. Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53
15. Activation of the cell death program by inhibition of proteasome function
16. Proteasome inhibitors induce mitochondria-independent apoptosis in human glioma cells
17. Inhibition of ubiquitin-proteasome pathway activates a caspase-3 (CPP32)-like protease and induces Bcl-2 cleavage in human M-07e leukemic cells
18. P53-dependent induction of apoptosis by proteasome inhibitors
19. Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons
20. Proteasomes play an essential role in thymocyte apoptosis
21. Macromolecular substrates for the ICE-like proteases during apoptosis
22. The role of the caspase family of cysteine proteases in apoptosis
23. Activation of caspases triggered by cytochrome c in vitro
24. Apaf-1, a protein homologous to C. elegans CED-4, participates in cytochrome-c dependent activation of caspase-3
25. Bcl-X1 interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation
26. The proto-oncogene Bcl-2 and its role in regulating apoptosis
27. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
28. Apoptosis in the pathogenesis and treatment of disease
29. Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes
30. The bryostatins
31. Isolation and structure of Bryostatin 1
32. A simple salting out procedure for extracting DNA from human nucleated cells
33. Overexpressed mitochondrial hinge protein, a cytochrome c-binding protein, accelerates apoptosis by enhancing the release of cytochrome c from mitochondria
34. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
35. Bryostatin 1 (bryol) induced monocytic differentiation is associated with enhanced c-fyn tyrosine kinase and M-CSF receptors
36. Proteasome inhibitors activate stress kinases and induce Hsp72. Diverse effects on apoptosis
37. Selective inhibition of apoptosis by TPA-induced differentiation of U937 leukemic cells
38. De novo expression of the class-A macrophage scavenger receptor conferring resistance to apoptosis in differentiated human THP-1 monocytic cells
39. Lipopolysaccharide inhibits TNF-induced apoptosis: Role of nuclear factor-κB activation and reactive oxygen intermediates
40. Fibronectin binding promotes a PKC-dependent modulation of NF-κB in human T cells
41. The cAMP-dependent protein kinase A and protein kinase C-β pathways synergistically interact to activate HIV-1 transcription in latently infected cells of monocyte/macrophage lineage
42. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control
43. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
44. Involvement of Bcl-2 cleavage in the acceleration of VP-16-induced U937 cell apoptosis
45. Conversion of Bcl-2 to a Bax-like death effector by caspases
46. The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition
47. Tumor necrosis factor α: Posttranscriptional stabilization of WAF1 mRNA in p53-deficient human leukemic cells
48. The role of protein stability in the cell cycle and cancer
49. The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-α-initiated apoptosis